Post job

Amgen's revenue is $33.4 billion.

What is Amgen's revenue?

Amgen's annual revenue is $33.4B. Zippia's data science team found the following key financial metrics about Amgen after extensive research and analysis.
  • Amgen's revenue growth from 2001 to 2024 is 732.33%.
  • Amgen has 22,000 employees, and the revenue per employee ratio is $1,519,272.
  • Amgen's peak quarterly revenue was $9.1B in 2024(q4).
  • Amgen peak revenue was $33.4B in 2024.
  • Amgen annual revenue for 2023 was 28.2B, 7.09% growth from 2022.
  • Amgen annual revenue for 2024 was 33.4B, 18.57% growth from 2023.

On this page

Most recent quarter revenue
$9.1B (Q4'2024)
Company most recent quarter revenue
Peak revenue
$33.4B (2024)
Company peak revenue
Revenue / employee
$1.5M
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Most recent quarter revenue
$9.1B (Q4'2024)
Company most recent quarter revenue
Peak revenue
$33.4B (2024)
Company peak revenue
Revenue / employee
$1.5M
Company revenue / employee

Amgen historical revenue

Amgen's peak revenue was $33.4B in 2024. The peak quarterly revenue was $9.1B in 2024(q4).

Amgen's revenue increased from $4.0b in 2001 to $33.4B currently. That's a 732.33% change in annual revenue.

Amgen annual revenue

$33B
$27B
$20B
$13B
$7B
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024

Amgen annual revenue over time

Fiscal year / yearAmgen revenue
2009$14.6B
2010$15.1B
2011$15.6B
2012$17.3B
2013$18.7B
2014$20.1B
2015$21.7B
2016$23.0B
2017$22.8B
2018$23.7B
2019$23.4B
2020$25.4B
2021$26.0B
2022$26.3B
2023$28.2B
2024$33.4B

How accurately did Amgen's revenue projections match actual performance?

Zippia waving zebra

Amgen annual growth

Amgen saw the greatest revenue growth in 2003, when revenue increased by 51.29%.

Amgen had the lowest revenue growth in 2009, when revenue changed by -2.41%.

Amgen annual growth rate over time

YearAmgen growth
2009
-2%
2010
3%
2011
4%
2012
11%
2013
8%
2014
7%
2015
8%
2016
6%
2017
-1%
2018
4%
2019
-2%
2020
9%
2021
2%
2022
1%
2023
7%
2024
19%

Amgen quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$9B
$7B
$5B
$4B
$2B
$0
2020
2021
2022
2023
2024

Amgen quarterly growth rate over time

YearQ1Q2Q3Q4
2009$3.3B$3.7B$3.8B$3.8B
2010$3.6B$3.8B$3.8B$3.8B
2011$3.7B$4.0B$3.9B$4.0B
2012$4.0B$4.5B$4.3B$4.4B
2013$4.2B$4.7B$4.7B$5.0B
2014$4.5B$5.2B$5.0B$5.3B
2015$5.0B$5.4B$5.7B$5.5B
2016$5.5B$5.7B$5.8B$6.0B
2017$5.5B$5.8B$5.8B$5.8B
2018$5.6B$6.1B$5.9B$6.2B
2019$5.6B$5.9B$5.7B$6.2B
2020$6.2B$6.2B$6.4B$6.6B
2021$5.9B$6.5B$6.7B$6.8B
2022$6.2B$6.6B$6.7B$6.8B
2023$6.1B$7.0B$6.9B$8.2B
2024$7.4B$8.4B$8.5B$9.1B

Amgen jobs nearby

Do you work at Amgen?

Did Amgen meet its revenue projections?

Amgen financial information

CEORobert A. Bradway
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number22,000
Date Founded1980
HeadquartersThousand Oaks, California
Number of Locations18
Revenue$33.4B
Net Income$6,552,000,000
Gross Proft$20.6B (2024)
EBITDA$6.2B (2010)
PE Ratio32.45
Tax Rate0.1%
Market Capitalization$132.7B
Total Assets$65,121,000,000
TickerAMGN

Amgen jobs you might like

Amgen financing

Amgen received early financing of $2.3B on 2011.

SeriesRound sizeDate
Other$2.5B2015
Other$2.5B2013
Other$2.3B2011

Amgen competitors

Amgen's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.

Amgen's smallest competitor is Human Genome Sciences with revenue of $131.0M last year.

Amgen revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Amgen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Amgen. The employee data is based on information from people who have self-reported their past or current employments at Amgen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Amgen. The data presented on this page does not represent the view of Amgen and its employees or that of Zippia.

Amgen may also be known as or be related to AMGEN INC, Amgen, Amgen Inc, Amgen Inc. and Applied Molecular Genetics (1980–1983).